B
NGVT icon

Bayban’s Ingevity NGVT Stock Holding History

Bayban’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12
Closed -$855 – 635
2026
Q1 		$855 Buy
+12
New +$821 ﹤0.01% 629

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Simcoe Capital Management New York $549M AUM 24.95% 1-Year Est. Return

Bayban's NGVT Position: Q2 2026 in Review

Bayban sold out of Ingevity (NGVT) in Q2 2026, closing a stake of 12 shares — an estimated $855 sold.

Bayban first reported a position in NGVT in Q1 2026 and held it in 1 quarter. The position peaked at $855 in Q1 2026. 290 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Bayban reported no remaining Ingevity position as of Q2 2026 after selling out during the quarter.
  • Bayban sold 12 Ingevity shares in Q2 2026, an estimated $855.
  • Bayban first reported a position in Ingevity in Q1 2026 and held it in 1 quarter.
  • Bayban's Ingevity position peaked at $855 in Q1 2026.
  • 290 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.